Gilead's Kite exits China cell therapy joint venture with Fosun Pharma

Gilead's Kite exits China cell therapy joint venture with Fosun Pharma

Source: 
Fierce Pharma
snippet: 

Gilead Sciences’ Kite Pharma will sell its stake in China’s Fosun Kite Biotechnology nearly eight years after forming the 50-50 cell-therapy-focused joint venture with Fosun Pharma.